114 related articles for article (PubMed ID: 20226572)
1. A note to the biological activity of benzoxazine derivatives containing the thioxo group.
Waisser K; Petrlíková E; Perina M; Klimesová V; Kunes J; Palát K; Kaustová J; Dahse HM; Möllmann U
Eur J Med Chem; 2010 Jul; 45(7):2719-25. PubMed ID: 20226572
[TBL] [Abstract][Full Text] [Related]
2. Highly active antimycobacterial derivatives of benzoxazine.
Petrlíková E; Waisser K; Divišová H; Husáková P; Vrabcová P; Kuneš J; Kolář K; Stolaříková J
Bioorg Med Chem; 2010 Dec; 18(23):8178-87. PubMed ID: 21044844
[TBL] [Abstract][Full Text] [Related]
3. Highly active potential antituberculotics: 3-(4-alkylphenyl)-4-thioxo-2H-1,3-benzoxazine-2(3H)-ones and 3-(4-alkylphenyl)-2H-1,3-benzoxazine-2,4(3H)-dihiones substituted in ring-B by halogen.
Waisser K; Matyk J; Kunes J; Dolezal R; Kaustová J; Dahse HM
Arch Pharm (Weinheim); 2008 Dec; 341(12):800-3. PubMed ID: 19006090
[TBL] [Abstract][Full Text] [Related]
4. New groups of antimycobacterial agents: 6-chloro-3-phenyl-4-thioxo-2H-1,3-benzoxazine-2(3H)-ones and 6-chloro-3-phenyl-2H-1,3-benzoxazine-2,4(3H)-dithiones.
Waisser K; Gregor J; Kubicová L; Klimesová V; Kunes J; Machácek M; Kaustová J
Eur J Med Chem; 2000; 35(7-8):733-41. PubMed ID: 10960190
[TBL] [Abstract][Full Text] [Related]
5. 3-Benzyl-2H-1,3-benzoxazine-2,4(3H)-diones, a new group of antimycobacterial compounds against potentially pathogenic strains.
Waisser K; Perina M; Kunes J; Klimesová V; Kaustová J
Farmaco; 2003 Nov; 58(11):1137-49. PubMed ID: 14572865
[TBL] [Abstract][Full Text] [Related]
6. [Antimicrobial salicylanilides and 3-phenyl-2H-1,3-benzoxazine-2,4(3H)-diones].
Waisser K; Gregor J; Holý P; Kubicová L; Klimesová V; Kaustová J
Ceska Slov Farm; 2001 May; 50(3):148-52. PubMed ID: 11394023
[TBL] [Abstract][Full Text] [Related]
7. High active potential antimycobacterial agents against Mycobacterium avium.
Karel W; Jiří K; Jiřina S
Ceska Slov Farm; 2012 Jun; 61(3):127-9. PubMed ID: 22913828
[TBL] [Abstract][Full Text] [Related]
8. Influence of the replacement of the oxo function with the thioxo group on the antimycobacterial activity of 3-aryl-6,8-dichloro-2H-1,3-benzoxazine-2,4(3H)-diones and 3-arylquinazoline-2,4(1H,3H)-diones.
Waisser K; Gregor J; Dostál H; Kunes J; Kubicová L; Klimesová V; Kaustová J
Farmaco; 2001 Oct; 56(10):803-7. PubMed ID: 11718275
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, antimicrobial activity and QSARs of new benzoxazine-3-ones.
Alper-Hayta S; Aki-Sener E; Tekiner-Gulbas B; Yildiz I; Temiz-Arpaci O; Yalcin I; Altanlar N
Eur J Med Chem; 2006 Dec; 41(12):1398-404. PubMed ID: 16996656
[TBL] [Abstract][Full Text] [Related]
10. N-benzylsalicylthioamides: highly active potential antituberculotics.
Dolezal R; Waisser K; Petrlíková E; Kunes J; Kubicová L; Machácek M; Kaustová J; Dahse HM
Arch Pharm (Weinheim); 2009 Feb; 342(2):113-9. PubMed ID: 19137534
[TBL] [Abstract][Full Text] [Related]
11. Antimycobacterial 3-aryl-2H-1,3-benzoxazine-2,4(3H)-diones.
Waisser K; Bures O; Holý P; Kunes J; Oswald R; Jirásková L; Pour M; Klimesová V; Palát K; Kaustová J; Danse HM; Möllmann U
Pharmazie; 2003 Feb; 58(2):83-94. PubMed ID: 12641321
[TBL] [Abstract][Full Text] [Related]
12. [New groups of potential antitubercular agents: 3-(4-ethoxythiocarbonylphenyl)-2-H-benzoxazin-2,4(3H)-diones and 3-(4-ethoxythiocarbonylphenyl)-4-thioxy-2H-benzoxazin-2(3H)-ones].
Waisser K; Holý P; Bures O; Kunes J; Kaustová J
Ceska Slov Farm; 2003 Jan; 52(1):42-7. PubMed ID: 12685334
[TBL] [Abstract][Full Text] [Related]
13. Quantitative structure-activity relationships for the in vitro antimycobacterial activity of pyrazinoic acid esters.
Bergmann KE; Cynamon MH; Welch JT
J Med Chem; 1996 Aug; 39(17):3394-400. PubMed ID: 8765523
[TBL] [Abstract][Full Text] [Related]
14. Antimycobacterial activity of 3'- and 4'-fluorothiobenzanilides.
Waisser K; Kunes J; Odlerová Z; Roman M; Kubicová L; Horák V
Pharmazie; 1998 Mar; 53(3):193-5. PubMed ID: 9547521
[TBL] [Abstract][Full Text] [Related]
15. Relationship between the structure and antimycobacterial activity of substituted salicylanilides.
Waisser K; Bures O; Holý P; Kunes J; Oswald R; Jirásková L; Pour M; Klimesová V; Kubicová L; Kaustová J
Arch Pharm (Weinheim); 2003 Mar; 336(1):53-71. PubMed ID: 12666254
[TBL] [Abstract][Full Text] [Related]
16. In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria.
Sohn H; Lee KS; Ko YK; Ryu JW; Woo JC; Koo DW; Shin SJ; Ahn SJ; Shin AR; Song CH; Jo EK; Park JK; Kim HJ
Int J Antimicrob Agents; 2008 Jun; 31(6):567-71. PubMed ID: 18337064
[TBL] [Abstract][Full Text] [Related]
17. Relationships between the chemical structure of antimycobacterial substances and their activity against atypical strains. Part 14: 3-Aryl-6,8-dihalogeno-2H-1,3-benzoxazine-2,4(3H)-diones.
Waisser K; Hladuvková J; Gregor J; Rada T; Kubicová L; Klimesová V; Kaustová J
Arch Pharm (Weinheim); 1998 Jan; 331(1):3-6. PubMed ID: 9507695
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and in vitro antimycobacterial activity of 2-methoxybenzanilides and their thioxo analogues.
Kozic J; Novotná E; Volková M; Stolaříková J; Trejtnar F; Vinšová J
Eur J Med Chem; 2012 Oct; 56():387-95. PubMed ID: 22907036
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antimycobacterial activity of 2-substituted halogenobenzimidazoles.
Kazimierczuk Z; Andrzejewska M; Kaustova J; Klimesova V
Eur J Med Chem; 2005 Feb; 40(2):203-8. PubMed ID: 15694655
[TBL] [Abstract][Full Text] [Related]
20. Acetophenones with selective antimycobacterial activity.
Rajabi L; Courreges C; Montoya J; Aguilera RJ; Primm TP
Lett Appl Microbiol; 2005; 40(3):212-7. PubMed ID: 15715647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
